UK markets open in 5 hours 43 minutes
NIKKEI 225
39,197.16 +127.48 (+0.33%) HANG SENG
19,636.22 +82.61 (+0.42%) CRUDE OIL
79.72 -0.08 (-0.10%) GOLD FUTURES
2,431.40 -7.10 (-0.29%) DOW
39,806.77 -196.82 (-0.49%) Bitcoin GBP
55,907.91 +3,712.97 (+7.11%)
Halozyme Therapeutics, Inc. (HALO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 5.69B |
| Enterprise value | 6.73B |
| Trailing P/E | 18.55 |
| Forward P/E | 14.90 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 6.84 |
| Price/book (mrq) | 32.00 |
| Enterprise value/revenue | 7.80 |
| Enterprise value/EBITDA | 13.58 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.26 |
| 52-week change 3 | 27.74% |
| S&P500 52-week change 3 | 26.49% |
| 52-week high 3 | 46.16 |
| 52-week low 3 | 31.86 |
| 50-day moving average 3 | 40.55 |
| 200-day moving average 3 | 38.83 |
Share statistics
| Avg vol (3-month) 3 | 1.03M |
| Avg vol (10-day) 3 | 1.23M |
| Shares outstanding 5 | 127.27M |
| Implied shares outstanding 6 | 128.48M |
| Float 8 | 125.89M |
| % held by insiders 1 | 1.11% |
| % held by institutions 1 | 98.99% |
| Shares short (30 Apr 2024) 4 | 8.41M |
| Short ratio (30 Apr 2024) 4 | 9.75 |
| Short % of float (30 Apr 2024) 4 | 8.93% |
| Short % of shares outstanding (30 Apr 2024) 4 | 6.61% |
| Shares short (prior month 28 Mar 2024) 4 | 7.89M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 36.94% |
| Operating margin (ttm) | 48.78% |
Management effectiveness
| Return on assets (ttm) | 13.48% |
| Return on equity (ttm) | 261.68% |
Income statement
| Revenue (ttm) | 862.99M |
| Revenue per share (ttm) | 6.64 |
| Quarterly revenue growth (yoy) | 20.80% |
| Gross profit (ttm) | N/A |
| EBITDA | 458.42M |
| Net income avi to common (ttm) | 318.8M |
| Diluted EPS (ttm) | 2.41 |
| Quarterly earnings growth (yoy) | 93.90% |
Balance sheet
| Total cash (mrq) | 463.45M |
| Total cash per share (mrq) | 3.64 |
| Total debt (mrq) | 1.53B |
| Total debt/equity (mrq) | 861.96% |
| Current ratio (mrq) | 6.64 |
| Book value per share (mrq) | 1.40 |
Cash flow statement
| Operating cash flow (ttm) | 431.03M |
| Levered free cash flow (ttm) | 320.33M |
© 2024 Yahoo. All rights reserved.